Monitor for subsequent Form 4 filings to confirm execution of the sale. The filing extends a recent insider selling pattern, which may signal reduced conviction at current valuation levels. Given the company's high analyst bullish consensus (93%), the selling could create short-term overhang.
Price Chart
Executive Summary
Officer Bruce N. Jacobs filed a Form 144 notice of intent to sell 77,109 shares of Kymera Therapeutics common stock, with an estimated aggregate market value of approximately $8.4 million. The shares derive from stock option exercises and restricted stock unit vesting, and the filing adds to a pattern of recent insider selling totaling $10.0M over the past 30 days.
Key Facts
- Bruce N. Jacobs, an officer of Kymera Therapeutics, filed Form 144 on 06/30/2026 indicating intent to sell 77,109 shares.
- Estimated aggregate market value of the proposed sale is $8,429,555.88 based on the filing date.
- Shares to be sold consist of 61,378 from stock option exercises and 15,731 from restricted stock unit vesting.
- Recent insider activity shows 7 sells totaling $10.0M in the last 30 days, adding to this selling trend.
Financial Impact
Proposed sale of ~$8.4M in shares, representing approximately 0.09% of Kymera's $9.4B market cap.
Risk Factors
- Insider selling may indicate a lack of confidence in near-term prospects or a desire to diversify.
- Additional insider sales could follow, increasing supply and weighing on the stock.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006647 |
| Document: 0001950047-26-006647-index.html | 0001950047-26-006647 |
| Document: 0001950047-26-006647.txt | 0001950047-26-006647 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $105.48 $118.63 | ▲ +12.47% | ▲ +13.07% | $107.39 (+1.81%) |
Jul 8, 2026 12w ago | Insider Cluster | $114.16 $105.48 | ▲ +7.60% | ▲ +10.88% | $107.39 (+5.93%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jun 30, 2026 13w ago | 144 | $114.20 $105.25 | ▲ +7.84% | ▲ +5.65% | $107.39 (+5.96%) |
Jun 29, 2026 13w ago | 144 | $114.67 $110.05 | ▼ −4.03% | ▼ −3.00% | $107.39 (−6.35%) |
Jun 26, 2026 13w ago | Insider Cluster | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 13w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 14w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 24, 2026 14w ago | 144 | $116.46 $110.38 | ▼ −5.22% | ▼ −5.75% | $107.39 (−7.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access